𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer

✍ Scribed by Christopher H Switzer, Robert Y-S Cheng, Lisa A Ridnour, Sharon A Glynn, Stefan Ambs, David A Wink

Book ID
118726951
Publisher
BioMed Central
Year
2012
Tongue
English
Weight
692 KB
Volume
14
Category
Article
ISSN
1465-5411

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

KAI1/CD82 is a novel target of estrogen
KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancer
✍ Matthias Christgen; Henriette Bruchhardt; Matthias Ballmaier; Till Krech; Floria πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 749 KB

## Abstract The cell‐surface glycoprotein KAI1 suppresses tumor growth and metastasis in various animal models. Downregulation of KAI1 has been implicated in the progression of cancer. However, the mechanisms of KAI1 inactivation are poorly understood. This is the first study that investigates expr

KAI1/CD82 is a novel target of estrogen
KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancer (Int J Cancer 123: 2239–2246, 2008)
✍ Joseph Geradts πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 43 KB πŸ‘ 1 views

With interest I read the article by Christgen et al. that was recently published under the Fast Track heading in the International Journal of Cancer. 1 The major reported findings, nicely summarized in the article's title, are that (a) KAI1/CD82 is downregulated in 77% of human breast carcinomas and